Your browser doesn't support javascript.
loading
HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting Strategies.
Udagawa, Hibiki; Nilsson, Monique B; Robichaux, Jacqulyne P; He, Junqin; Poteete, Alissa; Jiang, Hong; Heeke, Simon; Elamin, Yasir Y; Shibata, Yuji; Matsumoto, Shingo; Yoh, Kiyotaka; Okazaki, Shogo; Masuko, Takashi; Odintsov, Igor; Somwar, Romel; Ladanyi, Marc; Goto, Koichi; Heymach, John V.
Afiliação
  • Udagawa H; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
  • Nilsson MB; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Robichaux JP; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • He J; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Poteete A; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jiang H; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Heeke S; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Elamin YY; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Shibata Y; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
  • Matsumoto S; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
  • Yoh K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
  • Okazaki S; Department of Microbiology and Immunology, Nihon University School of Dentistry, Tokyo, Japan.
  • Masuko T; Cell Biology Laboratory, School of Pharmacy, Kindai University, Osaka, Japan.
  • Odintsov I; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Somwar R; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Ladanyi M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Goto K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
  • Heymach JV; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: jheymach@mdanderson.org.
J Thorac Oncol ; 19(1): 106-118, 2024 01.
Article em En | MEDLINE | ID: mdl-37678511
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão